ImmuCell Co. (NASDAQ:ICCC – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.09 and traded as high as $5.25. ImmuCell shares last traded at $5.16, with a volume of 3,319 shares traded.
ImmuCell Trading Down 5.8 %
The business’s 50-day moving average price is $4.70 and its two-hundred day moving average price is $4.09. The company has a current ratio of 3.11, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36.
ImmuCell Company Profile
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.
See Also
- Five stocks we like better than ImmuCell
- How to Calculate Stock Profit
- MP Materials: Rare Earth Elements Powering the EV Boom
- What is the S&P/TSX Index?
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- What is the Australian Securities Exchange (ASX)
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with MarketBeat.com's FREE daily email newsletter.
